← Leaderboards
Danny R Welch
University Of Kansas Medical Center
$4,556,425
Attributed
$4,751,168
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $399.8K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,751,168 · 7
By mechanism
R01$4,148,717 · 2
R21$389,486 · 1
P30$182,965 · 2
R13$30,000 · 1
P20$0 · 1
Top collaborators
- John A Taylor2 shared
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- John A Taylor$403,840
- Lauren M Aleksunes$14,275,663
Others in their field
Top investigators on “Neoplasm Metastasis”
- Charles A Coltman · Southwest Oncology Group$110,022,912
- Timothy J Eberlein · Washington University$54,581,241
- Samuel A Wells · Duke University$31,864,469
- William George Nelson · Johns Hopkins University$31,104,956
- Zaver M Bhujwalla · Johns Hopkins University$30,433,864
- Leonidas C Platanias · University Of Illinois At Chicago$30,290,986
Research focus
Neoplasm MetastasisTumorigenicityTumorCellsMalignant NeoplasmsMetastasis SuppressionResearch StudyPublicationsDisseminated Malignant NeoplasmKiss1 GeneIn VitroSignal TransductionNeoplastic CellFutureTissuesResponsePrimary NeoplasmProliferatingCessation Of LifeBasic ScienceMetastasisFluorescence MicroscopyAreaAffect
Grant awards (27)
Cancer Research Training & Education Coordination CRTEC$45,741
P30 · FY2025 · CA · contact PI
Regulatory Role of Mitochondrial DNA in Bladder Cancer Progression$172,098
R21 · FY2024 · CA
Cancer Research Training & Education Coordination CRTEC$45,742
P30 · FY2024 · CA · contact PI
Regulatory Role of Mitochondrial DNA in Bladder Cancer Progression$217,388
R21 · FY2023 · CA
Cancer Research Training & Education Coordination CRTEC$45,741
P30 · FY2023 · CA · contact PI
Cancer Research Training & Education Coordination CRTEC$45,741
P30 · FY2022 · CA · contact PI
KISS1: Defining Mechanisms for Antimetastatic Therapy$281,227
R01 · FY2014 · CA · contact PI
KISS1: Defining Mechanisms for Antimetastatic Therapy$275,619
R01 · FY2013 · CA · contact PI
KISS1: Defining Mechanisms for Antimetastatic Therapy$3,278
R01 · FY2012 · CA · contact PI
KISS1: Defining Mechanisms for Antimetastatic Therapy$294,464
R01 · FY2011 · CA · contact PI
KISS1: Defining Mechanisms for Antimetastatic Therapy$294,765
R01 · FY2010 · CA · contact PI
KISS1: Defining Mechanisms for Antimetastatic Therapy$322,870
R01 · FY2009 · CA · contact PI
Molecular regulation of breast cancer metastasis$303,343
R01 · FY2008 · CA · contact PI
Molecular regulation of breast cancer metastasis$75,409
R01 · FY2008 · CA · contact PI
International Congresses - Metastasis Research Society$21,000
R13 · FY2008 · CA · contact PI
Molecular regulation of breast cancer metastasis$309,344
R01 · FY2007 · CA · contact PI
Molecular regulation of breast cancer metastasis$73,466
R01 · FY2007 · CA · contact PI
Molecular regulation of breast cancer metastasis$318,584
R01 · FY2006 · CA · contact PI
International Congresses - Metastasis Research Society$1,000
R13 · FY2006 · CA · contact PI
Molecular regulation of breast cancer metastasis$326,250
R01 · FY2005 · CA
Molecular regulation of breast cancer metastasis$326,250
R01 · FY2004 · CA
International Congresses - Metastasis Research Society$8,000
R13 · FY2004 · CA
Core--Animal$0
P20 · FY2003 · CA
MOLECULAR REGULATION OF BREAST CANCER METASTASIS$284,796
R01 · FY2002 · CA
MOLECULAR REGULATION OF BREAST CANCER METASTASIS$35,265
R01 · FY2002 · CA
MOLECULAR REGULATION OF BREAST CANCER METASTASIS$314,568
R01 · FY2001 · CA
MOLECULAR REGULATION OF BREAST CANCER METASTASIS$309,219
R01 · FY2000 · CA